Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Sarah Milgrom to Neoplasms, Second Primary

This is a "connection" page, showing publications Sarah Milgrom has written about Neoplasms, Second Primary.

 
Connection Strength
 
 
 
0.904
 
  1. Milgrom SA, Paganetti H, Dama H, Renfro L, Wu Y, Meyer I, Jeeva M, Parsons SK, Punnett A, Charpentier AM, Lo AC, Vega RM, Keller FG, Kelly KM, Hoppe BS, Castellino SM, Hodgson D. Subsequent Neoplasm Risk After Modern Mediastinal Radiation Therapy for Pediatric Hodgkin Lymphoma: Insights From a Multi-Institutional Children's Oncology Group Trial. Int J Radiat Oncol Biol Phys. 2026 Jul 15; 125(4):1121-1129.
    View in: PubMed
    Score: 0.867
  2. Binkley MS, Rauf MS, Milgrom SA, Pinnix CC, Tsang R, Dickinson M, Ng AK, Roberts KB, Gao S, Balogh A, Ricardi U, Levis M, Casulo C, Stolten M, Specht L, Plastaras JP, Wright C, Kelsey CR, Brady JL, Mikhaeel NG, Hoppe BS, Terezakis SA, Picardi M, Della Pepa R, Kirova Y, Akhtar S, Maghfoor I, Koenig JL, Jackson C, Song E, Sehgal S, Advani RH, Natkunam Y, Constine LS, Eich HT, Wirth A, Hoppe RT. Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG. Blood. 2020 06 25; 135(26):2365-2374.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)